pharma news today obesity drugs glp-1 october 2025 Market Overview: Agonists and the Market | Blog GLP-1 Pipeline Update: August 2025

Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 safety profile)

Low-dose dexamethasone suppression testing (Gaab et al., 2002b) and prednisolone challenge experiments (Jerjes et al., 2007) both showed greater cortisol suppression in patients with ME/CFS than in healthy controls, supporting abnormal glucocorticoid feedback regulation

Its always best to mention new or worsening constipation to your prescriber

389(Pt 3): p

Conclusion: Ipamorelin vs CJC-1295 Ipamorelin and CJC-1295 are two of the most effective peptides for supporting fat loss, lean muscle, recovery, and anti-aging

Check out our before and after photos above if you want to see what were talking about